Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH and Acetazolamide in Idiopathic Intracranial Hypertension
NCT03963336Phase 1Completed
- Sponsor
- Fayoum University
- Start
- Jul 2017
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of enoxaparin in idiopathic intracranial hypertension (IIH), sponsored by Fayoum University. Primary endpoint: serum quantitative D-dimer. Started Jul 2017; status: completed.
02
Drugs
enoxaparin
03
Conditions
idiopathic intracranial hypertension (IIH)
Beyond the preview
Go deeper on NCT03963336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03963336.